Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) NowZacks Investment Research • 08/05/26
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/04/26
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class ProfileGlobeNewsWire • 08/04/26
5 Undervalued Price-to-Book Stocks Worth Adding to Your PortfolioZacks Investment Research • 07/28/26
Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock?Zacks Investment Research • 07/22/26
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026GlobeNewsWire • 07/21/26
Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO TransitionBusiness Wire • 07/16/26
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?Zacks Investment Research • 07/15/26
5 Low Price-to-Book Value Stocks to Buy in July for Solid ReturnsZacks Investment Research • 07/14/26
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?Zacks Investment Research • 06/29/26
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth PhaseZacks Investment Research • 06/29/26
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual MeetingBusiness Wire • 06/11/26
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26